Literature DB >> 21766274

[Pharmaceutical care in a visceral surgical ward].

R Schneider1, D Ranft, K Heinitz, D Uhlmann, J Hauss, R Frontini, S Leinung.   

Abstract

BACKGROUND: Medication errors and subsequent drug-related problems (DRPs) result from lack of sufficient information during the prescribing step. The objectives of this study were to evaluate the contribution of having a pharmacist participate in clinical routine on a surgical unit by studying DRPs, and the classification of DRPs in the Pharmaceutical Care Network Europe (PCNE) system.
MATERIALS AND METHODS: The pharmacotherapy of all patients of a visceral surgical ward was evaluated by a pharmacist in a prospective study design over a six-month period. The identified DRPs were classified using the PCNE system.
RESULTS: In 29 131 prescription lines, 697 DRPs were registered. This corresponds to a mean intervention rate of 2.4 %. All DRPs were classified into the modified PCNE system with 910 causes and 1 148 interventions. The most frequent DRPs were "lack of home medication" (35.6 %), drug dosing problems (18.6 %), the inappropriate duplication of drugs of the same therapeutic group (6.7 %) and drug interactions (6.5 %). 78.6 % vs. 3.7 % of all registered DRPs were completely vs. near completely resolved by pharmacist.
CONCLUSIONS: We consider the PCNE system with the four-level of classification to be a practical and easy-to-use tool in the daily hospital setting. Although we did not notice clinically relevant impairments of patient safety, a pharmacist may support the drug therapy and improve patient safety in clinics supporting the free choice of the drug therapy by the physician. © Georg Thieme Verlag KG Stuttgart ˙ New York.

Entities:  

Mesh:

Year:  2011        PMID: 21766274     DOI: 10.1055/s-0031-1271426

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  1 in total

1.  Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial.

Authors:  Salah AbuRuz; Deema Jaber; Iman Basheti; Aya Sadeq; Mosab Arafat; Mohammad AlAhmad; Amira Said
Journal:  Eur J Hosp Pharm       Date:  2020-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.